PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $310,000 | -42.6% | 101,947 | +65.2% | 0.00% | -75.0% |
Q4 2019 | $540,000 | +241.8% | 61,711 | +320.4% | 0.00% | +300.0% |
Q3 2019 | $158,000 | -72.4% | 14,678 | -67.5% | 0.00% | -80.0% |
Q2 2019 | $573,000 | +59.2% | 45,100 | +384.9% | 0.01% | +150.0% |
Q1 2019 | $360,000 | +16.5% | 9,300 | -38.8% | 0.00% | 0.0% |
Q4 2018 | $309,000 | -20.6% | 15,199 | +79.1% | 0.00% | +100.0% |
Q3 2018 | $389,000 | +872.5% | 8,486 | +1314.3% | 0.00% | – |
Q3 2016 | $40,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |